These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 25789779

  • 1. Whole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studies.
    Regacini R, Puchnick A, Shigueoka DC, Iared W, Lederman HM.
    Sao Paulo Med J; 2015; 133(2):141-50. PubMed ID: 25789779
    [Abstract] [Full Text] [Related]

  • 2. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
    Albano D, Patti C, La Grutta L, Agnello F, Grassedonio E, Mulè A, Cannizzaro G, Ficola U, Lagalla R, Midiri M, Galia M.
    Eur J Radiol; 2016 Feb; 85(2):313-8. PubMed ID: 26781135
    [Abstract] [Full Text] [Related]

  • 3. Comparison of diffusion-weighted MRI and [18F]FDG PET/MRI for treatment monitoring in pediatric Hodgkin and non-Hodgkin lymphoma.
    Morakote W, Baratto L, Ramasamy SK, Adams LC, Liang T, Sarrami AH, Daldrup-Link HE.
    Eur Radiol; 2024 Jan; 34(1):643-653. PubMed ID: 37542653
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.
    Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Elias SG, van de Brug T, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, Greer MC, de Keizer B, Nievelstein RAJ.
    Eur Radiol; 2021 Mar; 31(3):1494-1504. PubMed ID: 32880696
    [Abstract] [Full Text] [Related]

  • 7. Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?
    Regacini R, Puchnick A, Luisi FAV, Lederman HM.
    Pediatr Radiol; 2018 May; 48(5):638-647. PubMed ID: 29362839
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
    Herrmann K, Queiroz M, Huellner MW, de Galiza Barbosa F, Buck A, Schaefer N, Stolzman P, Veit-Haibach P.
    BMC Cancer; 2015 Dec 23; 15():1002. PubMed ID: 26699124
    [Abstract] [Full Text] [Related]

  • 9. Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
    Maccioni F, Alfieri G, Assanto GM, Mattone M, Gentiloni Silveri G, Viola F, De Maio A, Frantellizzi V, Di Rocco A, De Vincentis G, Pulsoni A, Martelli M, Catalano C.
    Radiol Med; 2023 May 23; 128(5):556-564. PubMed ID: 37145214
    [Abstract] [Full Text] [Related]

  • 10. Whole-Body Diffusion-Weighted MRI Compared to 18 FFDG PET/CT in Initial Staging and Therapy Response Assessment of Hodgkin Lymphoma in Pediatric Patients.
    Shapira-Zaltsberg G, Wilson N, Trejo Perez E, Abbott L, Dinning S, Kapoor C, Davila J, Smith B, Miller E.
    Can Assoc Radiol J; 2020 May 23; 71(2):217-225. PubMed ID: 32062992
    [Abstract] [Full Text] [Related]

  • 11. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
    Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F, Vandecaveye V.
    Eur Radiol; 2014 Apr 23; 24(4):889-901. PubMed ID: 24322510
    [Abstract] [Full Text] [Related]

  • 12. Whole-body MRI versus an [18F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma: a prospective multicentre study.
    Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, de Keizer B, Nievelstein RAJ.
    Eur Radiol; 2021 Dec 23; 31(12):8925-8936. PubMed ID: 34021390
    [Abstract] [Full Text] [Related]

  • 13. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
    van Ufford HM, Kwee TC, Beek FJ, van Leeuwen MS, Takahara T, Fijnheer R, Nievelstein RA, de Klerk JM.
    AJR Am J Roentgenol; 2011 Mar 23; 196(3):662-9. PubMed ID: 21343511
    [Abstract] [Full Text] [Related]

  • 14. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CT.
    Latifoltojar A, Punwani S, Lopes A, Humphries PD, Klusmann M, Menezes LJ, Daw S, Shankar A, Neriman D, Fitzke H, Clifton-Hadley L, Smith P, Taylor SA.
    Eur Radiol; 2019 Jan 23; 29(1):202-212. PubMed ID: 29948084
    [Abstract] [Full Text] [Related]

  • 15. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D, Patti C, Lagalla R, Midiri M, Galia M.
    J Magn Reson Imaging; 2017 Apr 23; 45(4):1082-1089. PubMed ID: 27603267
    [Abstract] [Full Text] [Related]

  • 16. Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard.
    Littooij AS, Kwee TC, Barber I, Granata C, Vermoolen MA, Enríquez G, Zsíros J, Soh SY, de Keizer B, Beek FJ, Hobbelink MG, Bierings MB, Stoker J, Nievelstein RA.
    Eur Radiol; 2014 May 23; 24(5):1153-65. PubMed ID: 24563179
    [Abstract] [Full Text] [Related]

  • 17. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE.
    Lancet Oncol; 2014 Mar 23; 15(3):275-85. PubMed ID: 24559803
    [Abstract] [Full Text] [Related]

  • 18. Whole-body MRI versus 18F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis.
    Wang D, Huo Y, Chen S, Wang H, Ding Y, Zhu X, Ma C.
    Onco Targets Ther; 2018 Mar 23; 11():3597-3608. PubMed ID: 29950864
    [Abstract] [Full Text] [Related]

  • 19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.
    Invest Radiol; 2016 Mar 23; 51(3):163-9. PubMed ID: 26784400
    [Abstract] [Full Text] [Related]

  • 20. Comparison of whole-body DW-MRI with 2-[18F]FDG PET for staging and treatment monitoring of children with Langerhans cell histiocytosis.
    Baratto L, Nyalakonda R, Theruvath AJ, Sarrami AH, Hawk KE, Rashidi A, Shen S, States L, Aboian M, Jeng M, Daldrup-Link HE.
    Eur J Nucl Med Mol Imaging; 2023 May 23; 50(6):1689-1698. PubMed ID: 36717409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.